Assignee
APCETH GMBH & CO KG
DE·2 granted patents·9 pending applications·28 citations·filing 2008–2021
Top patents by PatentIndex Score
11 records- 0186US7998472B2CD34 stem cell-related methods and compositionsAPCETH GMBH & CO KG·Filed 2008·Granted Aug 16, 2011·28 cites·7 claims
- 0261US12559724B2Genetically modified mesenchymal stem cell expressing KlothoAPCETH GMBH & CO KG·Filed 2021·Granted Feb 24, 2026·0 cites·25 claims
- 0348US2011268714A1CD34 Stem Cell-Related Methods and CompositionsAPCETH GMBH & CO KG·Filed 2011·Application pending·0 cites
- 0445US2019030152A1Mesenchymal stem cells to enhance anti-tumor activity of immunotherapyAPCETH GMBH & CO KG·Filed 2017·Application pending·0 cites
- 0544US2014087459A1Expansion Medium for CD34-Negative Stem CellsAPCETH GMBH & CO KG·Filed 2013·Application pending·0 cites
- 0644US2017015976A1Genetically modified mesenchymal stem cells that express an exogenous cytotoxic proteinAPCETH GMBH & CO KG·Filed 2016·Application pending·0 cites
- 0743US2016008401A1Protection of the vascular endothelium from immunologically mediated cytotoxic reactions with human cd34-negative progenitor cellsAPCETH GMBH & CO KG·Filed 2014·Application pending·0 cites
- 0842US2018037868A1Genetically modified mesenchymal stem cell expressing klothoAPCETH GMBH & CO KG·Filed 2016·Application pending·0 cites
- 0941US2014322786A1Polymer modified substrates, their preparation and uses thereofAPCETH GMBH & CO KG·Filed 2012·Application pending·0 cites
- 1040US2018000969A1Genetically modified mesenchymal stem cells expressing alpha-1 antitrypsin (aat)APCETH GMBH & CO KG·Filed 2016·Application pending·0 cites
- 1131US2017239297A1Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cellsAPCETH GMBH & CO KG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APCETH GMBH & CO KG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →